hiv yeztugo - Search News

News

FDA approves Yeztugo

The Jerusalem Post on MSN · 10h

FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection

He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the molecule lenacapavir, offers a more effective and less invasive prevention method,

CBS News on MSN · 2d

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

USA TODAY on MSN · 2d

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

2hon MSN

NIH office to phase out HIV guidelines by next year

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

99.9% breakthrough transforms HIV prevention forever

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results